- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05025202
Blood Pressure and Cardiac Autonomic Adaptations to Isometric Exercise Training
Blood Pressure and Cardiac Autonomic Adaptations to Isometric Exercise Training: a Randomised Sham-controlled Study
A randomized, sham-controlled intervention measuring the effects of isometric exercise training (IET) on blood pressure and cardiac autonomics.
IET has been proven effective in a plethora of randomized trials, but very little research has employed a sham-controlled design. This researched involved the recruitment of 30 participants who completed a 4 week IET intervention, sham control of the IET intervention, or a non-intervention control period. Pre and post blood pressure and cardiac autonomic measures were acquired and analysed.
The hypothesis of this trial was a significant effect of IET on blood pressure, with no such effects following the sham control or normal control interventions.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kent
-
Canterbury, Kent, United Kingdom
- Canterbury Christ Church University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy with no significant health conditions contraindicating exercise
- Over 18 years of age
- Physically inactive
Exclusion Criteria:
- Achieving current physical activity guidelines
- Abnormal resting ECG
- under 18
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: IET
Participants allocated to this arm performed 4 weeks of isometric wall squat exercise training, 3 times per week.
|
A form of exercise involving static contraction against a wall, sustained for 2 minutes x4 sets per session.
3 sessions a week were required.
The intensity was designed to achieve 95% of the participants maximum heart rate.
|
|
SHAM_COMPARATOR: Sham
Participants allocated to this arm performed 4 weeks of isometric wall squat training, but the training prescription was intentionally provided at an insufficient intensity to achieve any physiology stimulus.
|
A form of exercise involving static contraction against a wall, sustained for 2 minutes x4 sets per session.
3 sessions a week were required.
The intensity was designed to achieve 95% of the participants maximum heart rate.
|
|
NO_INTERVENTION: No intervention control
Participants allocated to this arm did not perform any exercise and were required to maintain usual daily habits.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure (systolic, diastolic and mean BP)
Time Frame: At the start of the intervention (pre 4 week intervention)
|
Resting office blood pressure measured at brachial artery
|
At the start of the intervention (pre 4 week intervention)
|
|
Blood pressure (systolic, diastolic and mean BP)
Time Frame: At the end of the intervention (post 4 weeks)
|
Resting office blood pressure measured at brachial artery
|
At the end of the intervention (post 4 weeks)
|
|
Cardiac autonomics measured at HRV
Time Frame: At the start of the intervention (pre 4 week intervention)
|
LF and HF power spectral measures
|
At the start of the intervention (pre 4 week intervention)
|
|
Cardiac autonomics measured at HRV
Time Frame: At the end of the intervention (post 4 weeks)
|
LF and HF power spectral measures
|
At the end of the intervention (post 4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
continuous 5-minute blood pressure (systolic, diastolic and mean BP)
Time Frame: At the start of the intervention (pre 4 week intervention)
|
5 minute mean of resting blood pressure measured beat-to-beat
|
At the start of the intervention (pre 4 week intervention)
|
|
continuous 5-minute blood pressure (systolic, diastolic and mean BP)
Time Frame: At the end of the intervention (post 4 weeks)
|
5 minute mean of resting blood pressure measured beat-to-beat
|
At the end of the intervention (post 4 weeks)
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18/SAS/47C
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Isometric exercise training
-
St George's, University of LondonNot yet recruitingHeart Failure With Preserved Ejection Fraction
-
University of PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo... and other collaboratorsCompleted
-
University of PernambucoFundação de Amparo à Pesquisa do Estado de São PauloCompletedPeripheral Artery DiseaseBrazil
-
Emory UniversityAmerican Heart AssociationRecruiting
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
KU LeuvenResearch Foundation FlandersCompleted
-
Mansoura UniversityCompletedEnd-Stage Renal Disease | Arteriovenous Fistula | Chronic Kidney FailureEgypt
-
University Institute of MaiaUniversity of Connecticut; Aveiro University; Hospital Infante D. Pedro, Centro... and other collaboratorsCompletedHypertension | Pre-HypertensionUnited States, Portugal
-
University of NottinghamThe Royal College of Surgeons of England; The Dunhill Medical TrustUnknownHypertension | Perioperative HypertensionUnited Kingdom